CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 33 filers reported holding CARDIOME PHARMA CORP in Q3 2016. The put-call ratio across all filers is 14.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,000 | +150.0% | 2,593 | +151.5% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 1,031 | -18.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,257 | +151.4% | 0.00% | – |
| Q2 2016 | $3,000 | -57.1% | 500 | -72.9% | 0.00% | -100.0% |
| Q1 2016 | $7,000 | +75.0% | 1,842 | +240.5% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | -63.6% | 541 | -61.8% | 0.00% | 0.0% |
| Q3 2015 | $11,000 | -77.1% | 1,417 | -72.2% | 0.00% | -75.0% |
| Q2 2015 | $48,000 | +26.3% | 5,096 | +24.3% | 0.00% | -20.0% |
| Q1 2015 | $38,000 | -25.5% | 4,100 | -24.5% | 0.01% | 0.0% |
| Q4 2014 | $51,000 | +50.0% | 5,433 | +61.3% | 0.01% | +25.0% |
| Q3 2014 | $34,000 | +21.4% | 3,368 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $28,000 | +133.3% | 3,334 | +156.5% | 0.00% | +100.0% |
| Q1 2014 | $12,000 | +300.0% | 1,300 | +160.0% | 0.00% | +100.0% |
| Q4 2013 | $3,000 | -57.1% | 500 | -75.7% | 0.00% | 0.0% |
| Q3 2013 | $7,000 | – | 2,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |